• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者血小板动力学评估:与特发性血小板减少性紫癜相似

Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura.

作者信息

Kajihara Mikio, Okazaki Yuka, Kato Shinzo, Ishii Hiromasa, Kawakami Yutaka, Ikeda Yasuo, Kuwana Masataka

机构信息

Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.

出版信息

J Gastroenterol Hepatol. 2007 Jan;22(1):112-8. doi: 10.1111/j.1440-1746.2006.04359.x.

DOI:10.1111/j.1440-1746.2006.04359.x
PMID:17201890
Abstract

BACKGROUND

Thrombocytopenia is a common manifestation of liver cirrhosis (LC), but its underlying mechanism is not fully understood. The purpose of the present paper was to evaluate the platelet kinetics in LC patients by examining several non-invasive convenient markers.

METHODS

Fifty-seven LC patients, 32 patients with idiopathic thrombocytopenic purpura (ITP), 12 with aplastic anemia (AA), and 29 healthy individuals were studied. Plasma thrombopoietin was measured by enzyme-linked immunosorbent assay. Absolute reticulated platelet (RP) count and plasma glycocalicin were used as indices for thrombopoiesis, and the indices for platelet turnover were the RP proportion and the plasma glycocalicin normalized to the individual platelet count (GCI).

RESULTS

There was no difference in thrombopoietin levels between LC patients and healthy controls. The RP proportion and GCI were significantly higher and the absolute RP count and glycocalicin significantly lower in LC patients than in healthy controls. These markers in ITP and LC patients were comparable, but significantly different from those in AA patients. The bone marrow megakaryocyte density in LC and ITP patients was similar, and significantly higher than in AA patients.

CONCLUSIONS

Cirrhotic thrombocytopenia is a multifactorial condition involving accelerated platelet turnover and moderately impaired thrombopoiesis. Thrombopoietin deficiency is unlikely to be the primary contributor to cirrhotic thrombocytopenia.

摘要

背景

血小板减少是肝硬化(LC)的常见表现,但其潜在机制尚未完全明确。本文旨在通过检测几种非侵入性便捷标志物来评估LC患者的血小板动力学。

方法

研究了57例LC患者、32例特发性血小板减少性紫癜(ITP)患者、12例再生障碍性贫血(AA)患者和29名健康个体。采用酶联免疫吸附测定法检测血浆血小板生成素。绝对网织血小板(RP)计数和血浆糖萼蛋白用作血小板生成指标,血小板周转率指标为RP比例和根据个体血小板计数标准化的血浆糖萼蛋白(GCI)。

结果

LC患者与健康对照者的血小板生成素水平无差异。LC患者的RP比例和GCI显著高于健康对照者,而绝对RP计数和糖萼蛋白显著低于健康对照者。ITP和LC患者的这些标志物具有可比性,但与AA患者的标志物显著不同。LC和ITP患者的骨髓巨核细胞密度相似,且显著高于AA患者。

结论

肝硬化性血小板减少是一种多因素疾病,涉及血小板周转率加快和血小板生成中度受损。血小板生成素缺乏不太可能是肝硬化性血小板减少的主要原因。

相似文献

1
Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura.肝硬化患者血小板动力学评估:与特发性血小板减少性紫癜相似
J Gastroenterol Hepatol. 2007 Jan;22(1):112-8. doi: 10.1111/j.1440-1746.2006.04359.x.
2
Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations.通过同时测定全血网织血小板和血清血小板生成素浓度评估血小板减少症中的血小板生成情况。
Thromb Haemost. 1998 Jun;79(6):1106-10.
3
Platelet production and destruction in liver cirrhosis.肝硬化中的血小板生成和破坏。
J Hepatol. 2011 May;54(5):894-900. doi: 10.1016/j.jhep.2010.08.018. Epub 2010 Dec 22.
4
Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia.网织血小板、血浆糖萼蛋白及血小板生成素水平检测对鉴别高破坏性与发育不全性血小板减少症的诊断价值
Am J Clin Pathol. 2001 May;115(5):656-64. doi: 10.1309/RAW2-0LQW-8YTX-941V.
5
[Comparison of reticulated platelet count with plasma glycocalicin concentration as a marker of platelet turnover in patients with thrombocytopenic disorders].[血小板减少性疾病患者中,网织血小板计数与血浆糖萼蛋白浓度作为血小板更新标志物的比较]
Rinsho Ketsueki. 2000 Sep;41(9):705-11.
6
Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.再生障碍性贫血和特发性血小板减少性紫癜患者中血小板和巨核细胞对血清血小板生成素水平的调节
Thromb Haemost. 1996 Aug;76(2):156-60.
7
Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.再生障碍性贫血和特发性血小板减少性紫癜患者的血浆血小板生成素水平
Chin Med J (Engl). 2002 Jul;115(7):983-6.
8
A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.自身抗体介导的血小板破坏在肝硬化患者血小板减少症中的作用。
Hepatology. 2003 Jun;37(6):1267-76. doi: 10.1053/jhep.2003.50209.
9
Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation.儿童慢性血小板减少症:无创方法在临床评估中的应用
Eur J Haematol. 2004 Apr;72(4):268-72. doi: 10.1111/j.1600-0609.2004.00215.x.
10
[The sensitivity, specificity and predictive value of PAIgG, reticulated platelets, thrombopoietin levels, and platelet size for the differential diagnosis of thrombocytopenia].[PAIgG、网织血小板、血小板生成素水平及血小板大小对血小板减少症鉴别诊断的敏感性、特异性及预测价值]
Rinsho Ketsueki. 1999 Nov;40(11):1152-9.

引用本文的文献

1
Hematological abnormalities in liver cirrhosis.肝硬化中的血液学异常。
World J Hepatol. 2024 Sep 27;16(9):1229-1244. doi: 10.4254/wjh.v16.i9.1229.
2
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南,2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
3
Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants.根据基础核心启动子/前核心突变对慢性乙型肝炎患者血清肝纤维化标志物的分析。
Sci Rep. 2022 Jun 17;12(1):10261. doi: 10.1038/s41598-022-14285-9.
4
Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p.血小板衍生的微颗粒通过 miR-1915-3p 增强巨核细胞分化和血小板生成。
Nat Commun. 2020 Oct 2;11(1):4964. doi: 10.1038/s41467-020-18802-0.
5
Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?慢性肝脏疾病和肝硬化的初级止血:过去十年我们学到了什么?
Int J Mol Sci. 2020 May 6;21(9):3294. doi: 10.3390/ijms21093294.
6
Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis.血清Ⅲ型前胶原N端肽对婴儿胆汁淤积性肝纤维化的诊断价值
Front Pediatr. 2020 Mar 31;8:131. doi: 10.3389/fped.2020.00131. eCollection 2020.
7
The assessment of liver fibrosis in children with obesity on two methods: transient and two dimensional shear wave elastography.两种方法评估肥胖儿童的肝纤维化:瞬时弹性成像和二维剪切波弹性成像。
Sci Rep. 2019 Dec 24;9(1):19800. doi: 10.1038/s41598-019-56358-2.
8
The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis Model.抗纤维化重组 nAG 蛋白在大鼠肝纤维化模型中的应用。
Biomed Res Int. 2019 Jun 2;2019:9846919. doi: 10.1155/2019/9846919. eCollection 2019.
9
Low platelet count: Predictor of death and graft loss after liver transplantation.血小板计数低:肝移植后死亡和移植物丢失的预测指标。
World J Hepatol. 2019 Jan 27;11(1):99-108. doi: 10.4254/wjh.v11.i1.99.
10
How do we diagnose immune thrombocytopenia in 2018?2018 年如何诊断免疫性血小板减少症?
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):561-567. doi: 10.1182/asheducation-2018.1.561.